WallStreetZenWallStreetZen

NASDAQ: CDXC
Chromadex Corp Stock Ownership - Who owns Chromadex?

Insider buying vs selling

Have Chromadex Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brianna GerberChief Financial Officer2023-12-015,000$1.41
$7.05kBuy
Frank L. Jaksch Jr.Director2023-06-127,000$1.69
$11.83kBuy
Robert N. FriedChief Executive Officer2023-05-317,000$1.42
$9.94kBuy
Steven D. RubinDirector2023-05-257,000$1.46
$10.22kBuy

1 of 1

CDXC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CDXC insiders and whales buy or sell their stock.

CDXC Shareholders

What type of owners hold Chromadex Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Barry C. Honig28.08%21,143,044$72.73MInsider
Champion River Ventures Ltd25.69%19,349,652$66.56MInsider
Michael Brauser20.21%15,219,914$52.36MInsider
Hoi Shuen Solina Holly Chau18.94%14,263,424$49.07MInsider
Frank L. Jaksch Jr.18.92%14,247,546$49.01MInsider
Phillip Md Et Al Frost16.73%12,602,939$43.35MInsider
Tricia A. Jaksch8.27%6,225,155$21.41MInsider
Sheep Flp Black8.27%6,225,155$21.41MInsider
Margie Chassman5.85%4,408,640$15.17MInsider
Pioneer Step Holdings Ltd5.11%3,846,155$13.23MInsider

1 of 3

CDXC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CDXC8.22%91.78%Net Buying
ENTA58.46%41.54%Net SellingNet Selling
IVVD37.84%62.16%Net Selling
VNDA56.23%43.77%Net SellingNet Selling
ADAP7.28%92.72%Net Selling

Chromadex Stock Ownership FAQ

Who owns Chromadex?

Chromadex (NASDAQ: CDXC) is owned by 15.36% institutional shareholders, 171.47% Chromadex insiders, and 0.00% retail investors. Barry C. Honig is the largest individual Chromadex shareholder, owning 21.14M shares representing 28.08% of the company. Barry C. Honig's Chromadex shares are currently valued at $72.73M.

If you're new to stock investing, here's how to buy Chromadex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.